KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

Yuichi Nozawa; Takeji Umemura; Satoru Joshita; Yoshihiko Katsuyama; Soichiro Shibata; Takefumi Kimura; Susumu Morita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota

doi:10.1371/journal.pone.0083381

Loading metrics

Open Access

Peer-reviewed

Research Article

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

Yuichi Nozawa ,

Contributed equally to this work with: Yuichi Nozawa, Takeji Umemura

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Takeji Umemura ,

Contributed equally to this work with: Yuichi Nozawa, Takeji Umemura

* E-mail: tumemura@shinshu-u.ac.jp (TU); otamasao@shinshu-u.ac.jp (MO)

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Satoru Joshita,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Yoshihiko Katsuyama,

Affiliation Department of Pharmacy, Shinshu University Hospital, Matsumoto, Japan
⨯
Soichiro Shibata,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Takefumi Kimura,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Susumu Morita,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Michiharu Komatsu,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Akihiro Matsumoto,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Eiji Tanaka,

Affiliation Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Masao Ota

* E-mail: tumemura@shinshu-u.ac.jp (TU); otamasao@shinshu-u.ac.jp (MO)

Affiliation Department of Legal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
⨯

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

Yuichi Nozawa,
Takeji Umemura,
Satoru Joshita,
Yoshihiko Katsuyama,
Soichiro Shibata,
Takefumi Kimura,
Susumu Morita,
Michiharu Komatsu,
Akihiro Matsumoto,
Eiji Tanaka

Published: December 12, 2013
https://doi.org/10.1371/journal.pone.0083381

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Chronic hepatitis
Is the Subject Area "Chronic hepatitis" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Immune receptors
Is the Subject Area "Immune receptors" applicable to this article?

Thanks for your feedback.
Variant genotypes
Is the Subject Area "Variant genotypes" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.
Killer activated and killer inhibitor receptors
Is the Subject Area "Killer activated and killer inhibitor receptors" applicable to this article?

Thanks for your feedback.
White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.